Concepedia

Author

Louis Desjardins

McGill University

Also Known As

Desjardins, L, L Desjardins, L. DESJARDINS, L. Desjardins, LOUIS DESJARDINS, Louis Desjardins

35

Publications

6.5K

Citations

17

H-Index

34

Concepts

All Affiliations

McGill UniversityUniversité LavalMcMaster UniversityUniversité de MontréalLund University
LD

About

Louis Desjardins is an author at McGill University specializing in thrombosis, medicine, and pulmonary embolism.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

1.5K

2

Public Health

4

4

969

3

Emergency Medicine

3

3

341

4

Health Sciences

2

2

108

5

Family Medicine

1

1

490

Louis Desjardins

×

18

Publications

6.5K

Citations

17

H-Index

YearCitations

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

M Samama, Alexander T. Cohen, Jean‐Yves Darmon,

New England Journal of Medicine

1999

1.6K

A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis

Mark Levine, Michael Gent, Jack Hirsh,

New England Journal of Medicine

1996

1.2K

A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism

Clive Kearon, Michael Gent, Jack Hirsh,

New England Journal of Medicine

1999

1.1K

Determinants of health‐related quality of life during the 2 years following deep vein thrombosis

Susan R. Kahn, Hadia Shbaklo, Donna L. Lamping,

Journal of Thrombosis and Haemostasis

2008

490

Risk Factors for Venous Thromboembolism in Hospitalized Patients With Acute Medical Illness

Raza Alikhan, Alexander T. Cohen, S. Combe,

Archives of Internal Medicine

2004

464

Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin

M.J. Kovacs, Clive Kearon, Marc Rodger,

Circulation

2004

327

Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada

Susan R. Kahn, Akbar Panju, William Geerts,

Thrombosis Research

2006

283

Prevention of venous thromboembolism in medical patients with enoxaparin

Raza Alikhan, Alexander T Cohen, S. Combe,

Blood Coagulation & Fibrinolysis

2003

244

Prevention of Deep Vein Thrombosis after Major Knee Surgery - A Randomized, Double-Blind Trial Comparing a Low Molecular Weight Heparin Fragment (Enoxaparin) to Placebo

Jacques R. Leclerc, William Geerts, Louis Desjardins,

Thrombosis and Haemostasis

1992

225

VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosis

Susan R. Kahn, Donna L. Lamping, Thiérry Ducruet,

Journal of Clinical Epidemiology

2006

194

Page 1